Correction: Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients

Mol Cancer. 2022 Aug 10;21(1):162. doi: 10.1186/s12943-022-01632-7.

Qing Ouyang^#^{1

2}, Xueyang Gong^#², Hualiang Xiao^#³, Ji Zhou¹, Minhui Xu¹, Yun Dai⁴, Lunshan Xu¹, Hua Feng⁵, Hongjuan Cui⁶, Liang Yi⁷

¹ Department of Neurosurgery, Daping Hospital, Third Military Medical University, Chongqing, China.
² State Key Laboratory of Silkworm Genome Biology, Institute of Sericulture and Systems Biology, Southwest University, Chongqing, China.
³ Department of Pathology, Daping Hospital, Third Military Medical University, Chongqing, China.
⁴ Division of Hematology/Oncology, Department of Medicine, Virginia Commonwealth University, Richmond, VA, USA.
⁵ Department of Neurosurgery, Southwest Hospital, Third Military Medical University, Chongqing, China.
⁶ State Key Laboratory of Silkworm Genome Biology, Institute of Sericulture and Systems Biology, Southwest University, Chongqing, China. hongjuan.cui@gmail.com.
⁷ Department of Neurosurgery, Daping Hospital, Third Military Medical University, Chongqing, China. happyape@126.com.

^# Contributed equally.

No abstract available

Publication types